Skip to main content
. 2019 Sep 3;8(9):1378. doi: 10.3390/jcm8091378

Table 2.

Risks for end-stage renal disease (ESRD), stroke or systemic thromboembolism, acute myocardial infarction (AMI), and mortality among patients with CKD by AF status.

Outcome Event IR (95% CI) Weighted Time-Dependent Cox Model
cHR (95% CI) p-Value aHR (95% CI) p-value aHR (95% CI) p-Value
ESRD
Non-AF 3440 51.84 (50.11–53.57) 1 1 0.34 (0.32–0.36) <0.0001
Prevalent AF 89 44.99 (35.64–54.34) 1.29 (1.22–1.36) <0.001 1.40 (1.32–1.48) <0.001 0.48 (0.45–0.51) <0.0001
Incident AF 95 85.19 (68.06–102.32) 3.05 (2.88–3.23) <0.001 2.91 (2.74–3.09) <0.001 1
Stroke or systemic thromboembolism
Non-AF 1247 17.04 (16.09–17.98) 1 1 0.61 (0.56–0.66) <0.0001
Prevalent AF 89 46.44 (36.79–56.09) 2.02 (1.88–2.16) <0.001 1.89 (1.77–2.03) <0.001 1.14 (1.05–1.25) 0.002
Incident AF 79 60.55 (47.19–73.9) 2.51 (2.33–2.72) <0.001 1.67 (1.54–1.81) <0.001 1
Acute myocardial infarction
Non-AF 461 6.08 (5.52–6.63) 1 1 0.50 (0.44–0.57) <0.0001
Prevalent AF 26 12.4 (7.64–17.17) 1.34 (1.18–1.52) <0.001 1.24 (1.09–1.41) 0.001 0.62 (0.53–0.72) <0.0001
Incident AF 28 19.07 (12.01–26.13) 3.02 (2.67–3.41) <0.001 1.99 (1.75–2.27) <0.001 1
All-cause mortality
Non-AF 3399 44.31 (42.82–45.8) 1 1 0.46 (0.44–0.49) <0.0001
Prevalent AF 219 102.1 (88.58–115.62) 1.83 (1.74–1.92) <0.001 1.64 (1.56–1.72) <0.001 0.76 (0.72–0.81) <0.0001
Incident AF 251 161.71 (141.7–181.72) 3.11 (2.96–3.27) <0.001 2.17 (2.06–2.29) <0.001 1
Cardiovascular mortality
Non-AF 452 5.89 (5.35–6.44) 1 1 0.22 (0.19–0.25) <0.0001
Prevalent AF 40 18.65 (12.87–24.43) 3.18 (2.83–3.57) <0.001 2.95 (2.62–3.32) <0.001 0.64 (0.57–0.72) <0.0001
Incident AF 59 38.01 (28.31–47.71) 6.81 (6.08–7.63) <0.001 4.61 (4.09–5.20) <0.001 1

Confidence interval (CI); hazard ratio (HR); incidence rate (IR; per 1000 person-years); end-stage renal disease (ESRD); acute myocardial infarction (AMI); chronic kidney disease (CKD); atrial fibrillation (F). aHR was calculated from adjustment for all variables in Table 1.